DT-PACE regimen: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{AV}}
{{CMG}}; {{AE}} {{AV}}


{{SK}}Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen
{{SK}} Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen


==Overview==
==Overview==
Line 10: Line 10:


==Regimen==
==Regimen==
{{chemo|D|Dexamethasone}}
{{chemo|D|Dexamethasone}}


Line 24: Line 23:


==Indications==
==Indications==
*Relapsed and refractory [[multiple myeloma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref>
*Relapsed and refractory [[multiple myeloma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref>



Latest revision as of 03:23, 13 March 2015

WikiDoc Resources for DT-PACE regimen

Articles

Most recent articles on DT-PACE regimen

Most cited articles on DT-PACE regimen

Review articles on DT-PACE regimen

Articles on DT-PACE regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on DT-PACE regimen

Images of DT-PACE regimen

Photos of DT-PACE regimen

Podcasts & MP3s on DT-PACE regimen

Videos on DT-PACE regimen

Evidence Based Medicine

Cochrane Collaboration on DT-PACE regimen

Bandolier on DT-PACE regimen

TRIP on DT-PACE regimen

Clinical Trials

Ongoing Trials on DT-PACE regimen at Clinical Trials.gov

Trial results on DT-PACE regimen

Clinical Trials on DT-PACE regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on DT-PACE regimen

NICE Guidance on DT-PACE regimen

NHS PRODIGY Guidance

FDA on DT-PACE regimen

CDC on DT-PACE regimen

Books

Books on DT-PACE regimen

News

DT-PACE regimen in the news

Be alerted to news on DT-PACE regimen

News trends on DT-PACE regimen

Commentary

Blogs on DT-PACE regimen

Definitions

Definitions of DT-PACE regimen

Patient Resources / Community

Patient resources on DT-PACE regimen

Discussion groups on DT-PACE regimen

Patient Handouts on DT-PACE regimen

Directions to Hospitals Treating DT-PACE regimen

Risk calculators and risk factors for DT-PACE regimen

Healthcare Provider Resources

Symptoms of DT-PACE regimen

Causes & Risk Factors for DT-PACE regimen

Diagnostic studies for DT-PACE regimen

Treatment of DT-PACE regimen

Continuing Medical Education (CME)

CME Programs on DT-PACE regimen

International

DT-PACE regimen en Espanol

DT-PACE regimen en Francais

Business

DT-PACE regimen in the Marketplace

Patents on DT-PACE regimen

Experimental / Informatics

List of terms related to DT-PACE regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen

Overview

DT-PACE regimen refers to a regimen consisting of dexamethasone, thalidomide (DT) and cisplatin, doxorubicin, cyclophosphamide and etoposide (PACE) used for the treatment of relapsed and refractory multiple myeloma.[1]

Regimen

DDexamethasone

TThalidomide

PCisplatin

ADoxorubicin (Adriamycin)

CCyclophosphamide

EEtoposide

Indications

References

  1. "NCI Thesaurus".
  2. "NCI Thesaurus".